Share

Manufacturer

Panagene

Application

Gene mutations testing and targeted response to cancer therapy

Products of interest

Batch Convert Unplayable Videos

Zymot ICSI

Next-Generation Sequencing System – NextSeq 2000
 Gene mutations testing and targeted response to cancer therapy

In cancer treatments, targeted therapy is the foundation of precision medicine, is one of the basic methods of an important treatment of multiple cancer paradigms by targeting to cancer cells in the process of growth, division and spread.

Targeted treatment in cancer works by attacking and blocking the specific genes or proteins which involved in tumor growth of cancer cells.

Biomedic's solution

By using test kits of Panagene in order to identify gene mutations for in therapy of targeted cancer, Biomedic provides solutions of Panagene:
  • Obtained CE-IVD certification for clinical diagnosis
  • Number of gene mutations detected: 13 target genes
  • Compatible devices: Various real-time PCR systems: CFX96, QS5,
    ABI 7500, Rotor Gene Q,…
  • Technology: PNAClamp Realtime PCR Advanced
    exactly
  • Sensitivity, specificity: 1% LOD with 10ng DNA
  • Kit Type: Ready-to-use
  • Input pattern: Fresh tissue or candle inclusion pattern FFPE

Product

PNAClamp™ EGFR (ver.2)

Code: PNAC-3002

Packing: 25 tests/set

Certificate: CE-IVD

PNAClamp™ EGFR Mutation Detection Kit (ver.2)

Code: PNAC-3002

Packing: 25 tests/set

Certificate: CE-IVD

PNAClamp™ KRAS (ver.4)

Code: PNAR-1006

Packing: 25 Pounds/set

Certificate: CE-IVD

PNAClamp™ NRAS Mutation Detection Kit

 

Code: PNAC-1101 (43 mutations)

Packing: 25 tests/set

Certificate: CE-IVD

Share

Manufacturer

Panagene

Application

Gene mutations testing and targeted response to cancer therapy

Products of interest

Batch Convert Unplayable Videos

Zymot ICSI

Next-Generation Sequencing System – NextSeq 2000